Genotoxic and cytotoxic effects of testosterone cypionate (deposteron(®))

José Roberto C Meireles1, Susie V Oliveira, Antônio O Costa-Neto

  • 1Department of Biological Sciences, Feira de Santana State University, Feira de Santana, Bahia, Brazil. jrcmeireles@gmail.com

Mutation Research
|March 12, 2013
PubMed

Insights

Testosterone cypionate (deposteron) demonstrates genotoxic and cytotoxic effects in mice. This study found increased micronuclei and decreased erythrocyte production following deposteron administration, highlighting potential risks associated with its use.

Area of Science:

  • Toxicology
  • Genetics
  • Pharmacology

Background:

  • Anabolic androgenic steroids (AAS) are frequently misused, prompting research into their mutagenic potential.
  • Understanding the genotoxic effects of specific AAS is crucial for public health and safety.

Purpose of the Study:

  • To evaluate the genotoxic and cytotoxic potential of testosterone cypionate (deposteron) using an in vivo mouse model.
  • To assess the dose-dependent effects of deposteron on bone marrow cells.

Main Methods:

  • The mouse bone marrow micronucleus test was employed to assess genotoxicity.
  • Male Swiss mice were administered intramuscular injections of deposteron at varying doses.
  • Micronuclei counts in polychromatic erythrocytes (PCE) and the PCE/NCE ratio were analyzed at 24, 48, and 72 hours post-treatment.

Main Results:

  • A significant increase in micronuclei formation was observed in animals treated with the highest dose of deposteron.
  • The highest dose of deposteron induced a decrease in the PCE/NCE ratio, indicating cytotoxic effects on bone marrow.
  • Dose-dependent genotoxic and cytotoxic effects were evident.

Conclusions:

  • Testosterone cypionate (deposteron) exhibits genotoxic activity in mice.
  • Deposteron also demonstrates cytotoxic effects, impacting bone marrow cell proliferation.
  • The findings suggest that deposteron poses risks associated with its indiscriminate use.

Related Concept Videos

Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...